AzTrials
AzTrials

Reproductive BehaviorREFLECTNCT06199726

REFLECT: Reproductive Education and Fertility Links for Cancer Treatment

An observational study of Reproductive Behavior, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate a web-based education tool geared at helping Adolescent and Young Adult (AYA) patients better understand fertility and genetic risks for cancer in future offspring. Read more about this study

Who is it for?
Ages 18 to 39 years
Conditions the study is for
Reproductive Behavior
What is being tested?
REFLECT web-based tool
How many people
16 participants
Where
1 siteUnited States
Study dates
11 Dec 2023to 5 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Adults ages 18-39 who have received cancer care at Moffitt and have children or are considering having a chilid in the future.

Who may be able to join

  • Adults between the ages of 18-39
  • Must have received Cancer care at Moffitt Cancer Center
  • Participants must consider having a child in the future or have had children at the time of diagnosis
  • Participants must be able to speak and read English
  • Participants must have access to a device that can connect to the internet

Who cannot join

  • Any participants who do not meet all Inclusion Criteria

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Moffitt Cancer Center

    Tampa, Florida, 33612

Other trials in United States

About this study

The purpose of this study is to evaluate a web-based education tool geared at helping Adolescent and Young Adult (AYA) patients better understand fertility and genetic risks for cancer in future offspring.

Being tested
REFLECT web-based tool
Keywords
Fertility
Medical subject headings
Reproductive Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • REFLECT web-based toolBehavioural

    Partnering with Nest Genomics, Investigators have developed a customizable web-based tool to support AYA patients through their cancer diagnosis journey for topics related to future family building and genetics. This interactive tool will include educational content to organize knowledge, make connections between concepts, and will include web links to more in-depth content and embedded videos. The interface will allow users to document questions that would be helpful in provider discussions and include decision support to assist with determining values and needs for proceeding with consultations related to genetic counseling and testing, and fertility.

Study groups in NCT06199726
Study groupRoleWhat they receive
Round 1 Interviews and/or Focus GroupApproximately12 people will be recruited complete interviews or focus groups in Round 1. The participants will be provided with the REFLECT tool. There will be interviews and discussions via telephone or ZOOM and feedback will be obtained to enhance the REFLECT tool.
Receives: Behavioral: REFLECT web-based tool
Round 2 Interviews and/or Focus GroupApproximately 13 people will be recruited to complete interviews or focus group in Round 2. The participants will be provided with the REFLECT tool that has been modified to include feedback from Round 1 interviews/focus groups. There will be interviews and discussions via telephone or ZOOM and feedback will be obtained on the enhanced tool.
Receives: Behavioral: REFLECT web-based tool

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ease of use of the REFLECT tool

    System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)

    Measured: One Year

  2. Confidence in use of the REFLECT tool

    System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)

    Measured: One Year

  3. Complexity of use of the REFLECT tool

    System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)

    Measured: One Year

  4. Desire to use the REFLECT tool

    System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)

    Measured: One Year

  5. Perception of inconsistencies of the REFLECT tool

    System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)

    Measured: One Year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2024
  2. Study start11 Dec 2023
  3. Primary completion5 Dec 2025
  4. Study completion5 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06199726
Sponsor's protocol ID
MCC-22569
Acronym
REFLECT
Status last verified
May 2026
First submitted
28 Dec 2023
Last updated
26 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Reproductive Behavior, run by H. Lee Moffitt Cancer Center and Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 26 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ease of use of the REFLECT tool (time frame: One Year). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in